SOLV – Solventum Corp
SOLV — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.69
Margin Of Safety %
Put/Call OI Ratio
0.3
EPS Next Q Diff
1.3
EPS Last/This Y
-2.48
EPS This/Next Y
0.58
Price
62.76
Target Price
88
Analyst Recom
2.6
Performance Q
-21.73
Upside
210.9%
Beta
0.8
Ticker: SOLV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | SOLV | 68.56 | 0.45 | 20.63 | 8085 |
| 2026-03-10 | SOLV | 67.62 | 0.46 | 0.50 | 8100 |
| 2026-03-11 | SOLV | 67.58 | 0.46 | 1.00 | 8094 |
| 2026-03-12 | SOLV | 66.15 | 0.47 | 0.45 | 8129 |
| 2026-03-13 | SOLV | 66.12 | 0.47 | 0.73 | 8129 |
| 2026-03-17 | SOLV | 68.67 | 0.37 | 0.08 | 7677 |
| 2026-03-18 | SOLV | 67.11 | 0.36 | 0.12 | 7886 |
| 2026-03-19 | SOLV | 67.14 | 0.36 | 0.77 | 7886 |
| 2026-03-20 | SOLV | 65.77 | 0.33 | 0.76 | 7768 |
| 2026-03-23 | SOLV | 65.69 | 0.32 | 0.02 | 6706 |
| 2026-03-24 | SOLV | 64.03 | 0.29 | 0.85 | 6981 |
| 2026-03-25 | SOLV | 64.6 | 0.30 | 0.36 | 7158 |
| 2026-03-26 | SOLV | 64.73 | 0.30 | 0.52 | 7360 |
| 2026-03-27 | SOLV | 62.76 | 0.30 | 0.84 | 7384 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | SOLV | 68.60 | 0.7 | -783.5 | 6.47 |
| 2026-03-10 | SOLV | 67.65 | 0.7 | -785.6 | 6.47 |
| 2026-03-11 | SOLV | 67.62 | 0.7 | -772.1 | 6.47 |
| 2026-03-12 | SOLV | 66.18 | 0.7 | -792.6 | 6.47 |
| 2026-03-13 | SOLV | 66.74 | 0.7 | -763.5 | 6.47 |
| 2026-03-17 | SOLV | 68.67 | 0.7 | -750.8 | 6.47 |
| 2026-03-18 | SOLV | 67.09 | 0.7 | -794.4 | 6.47 |
| 2026-03-19 | SOLV | 67.15 | 0.7 | -1330.6 | 6.47 |
| 2026-03-20 | SOLV | 65.78 | 0.7 | -1341.9 | 6.47 |
| 2026-03-23 | SOLV | 65.71 | 0.7 | -1331.6 | 6.47 |
| 2026-03-24 | SOLV | 64.03 | 0.7 | -1344.5 | 6.47 |
| 2026-03-25 | SOLV | 64.61 | 0.7 | -1326.3 | 6.47 |
| 2026-03-26 | SOLV | 64.75 | 0.7 | -1330.1 | 6.47 |
| 2026-03-27 | SOLV | 62.76 | 0.9 | -1347.1 | 6.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-06 | SOLV | 0.00 | 1.49 | 2.40 |
| 2026-03-09 | SOLV | 0.00 | 1.48 | 2.40 |
| 2026-03-10 | SOLV | 0.00 | 1.48 | 2.40 |
| 2026-03-11 | SOLV | 0.01 | 1.48 | 2.36 |
| 2026-03-12 | SOLV | 0.01 | 1.48 | 2.36 |
| 2026-03-13 | SOLV | 0.01 | 1.48 | 2.36 |
| 2026-03-17 | SOLV | 0.01 | 1.49 | 2.36 |
| 2026-03-18 | SOLV | 0.01 | 1.49 | 2.36 |
| 2026-03-19 | SOLV | 0.01 | 1.49 | 2.36 |
| 2026-03-20 | SOLV | 0.01 | 1.49 | 2.36 |
| 2026-03-23 | SOLV | 0.01 | 1.54 | 2.36 |
| 2026-03-24 | SOLV | 0.01 | 1.54 | 2.36 |
| 2026-03-25 | SOLV | 0.01 | 1.54 | 2.69 |
| 2026-03-26 | SOLV | 0.01 | 1.54 | 2.69 |
| 2026-03-27 | SOLV | 0.01 | 1.54 | 2.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.36
Avg. EPS Est. Current Quarter
1.35
Avg. EPS Est. Next Quarter
1.66
Insider Transactions
0.01
Institutional Transactions
1.54
Beta
0.8
Average Sales Estimate Current Quarter
1968
Average Sales Estimate Next Quarter
2069
Fair Value
Quality Score
91
Growth Score
76
Sentiment Score
41
Actual DrawDown %
34.7
Max Drawdown 5-Year %
Target Price
88
P/E
7.07
Forward P/E
8.94
PEG
1.1
P/S
1.3
P/B
2.16
P/Free Cash Flow
EPS
8.87
Average EPS Est. Cur. Y
6.46
EPS Next Y. (Est.)
7.04
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
18.64
Relative Volume
1.16
Return on Equity vs Sector %
3.5
Return on Equity vs Industry %
21.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.12
EBIT Estimation
-1347.1
◆
SOLV
Healthcare
$62.76
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
27.3
Range 1M
2.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
6%
EPS NY
8.5%
52W%
8.3%
Long-Term Value
Quality companies, undervalued
WATCH
🟢 BUY
+116.3% upside
Upside
+116.3%
Quality
91
Solventum CorporationSector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 20584
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
SOLV
Latest News
—
Caricamento notizie per SOLV…
stock quote shares SOLV – Solventum Corp Stock Price stock today
news today SOLV – Solventum Corp stock forecast ,stock prediction 2023 2024 2025
marketwatch SOLV – Solventum Corp yahoo finance google finance
stock history SOLV – Solventum Corp invest stock market
stock prices SOLV premarket after hours
ticker SOLV fair value insiders trading